#USA #oral health #Reisterstown #Real Diagnostics #SimplyTest

Real Diagnostics Acquires SimplyTest for Enhanced Oral Health Testing

In a significant move to expand its service offerings, Real Diagnostics has announced the acquisition of SimplyTest®, a leader in saliva-based diagnostic solutions, specifically targeting oral health. This acquisition, while the financial details remain undisclosed, marks a pivotal moment for Real Diagnostics as it diverse its portfolio to include advanced testing options for dental providers.

Expanding the Lab's Offerings

Real Diagnostics, a clinical laboratory certified by CLIA, has long specialized in high-complexity molecular infectious disease and toxicology testing. With this acquisition, Real Diagnostics is set to incorporate SimplyTest's flagship product, PERIO, which utilizes a unique non-invasive swish-and-spit saliva collection technique. This innovative approach allows for the accurate identification of key periodontal pathogens, enabling clinicians to tailor treatments based on organism-level data and closely monitor periodontal health over time.

The integration of these saliva-based diagnostics not only enhances the breadth of testing services available to providers but also strengthens Real Diagnostics' commitment to delivering cutting-edge healthcare solutions. Cary Breese, CEO of Real Diagnostics, expressed enthusiasm about the incorporation of SimplyTest's innovative leadership and dedicated team, which has redefined standards in the industry. Breese highlighted that this acquisition aligns seamlessly with their mission to humanize healthcare, allowing Real Diagnostics to provide dental practices with the most advanced diagnostic tools designed to improve patient outcomes.

Strategic Benefits for Providers and Patients

The addition of SimplyTest's products presents numerous benefits for healthcare providers and their patients. By consolidating oral health testing into a single laboratory relationship, providers can streamline their testing options. This continuity of service ensures that the quality and support that SimplyTest’s PERIO product has provided will remain uninterrupted. All testing will continue to meet CLIA-certified laboratory standards, assuring high-quality results.

Clients of SimplyTest can remain connected to support through their dedicated Provider Portal, ensuring that the transition into Real Diagnostics' broader service model is as smooth as possible. This development is particularly beneficial as it extends Real Diagnostics' reach into new provider types, including dental practices, which were previously outside their primary focus.

Real Diagnostics at a Glance

Real Diagnostics stands out as a high-complexity clinical laboratory specializing in advanced molecular biology, microbiology, and toxicology services. Utilizing cutting-edge Polymerase Chain Reaction (PCR) technology, the lab is known for delivering rapid diagnostic results that enhance clinical outcomes and support effective antimicrobial usage. The firm partners with hundreds of hospitals, physicians, and healthcare facilities nationwide, providing clear reporting and an integrated, secure results portal to enhance the overall healthcare experience.

As healthcare continues to evolve, Real Diagnostics' acquisition of SimplyTest is a significant step toward addressing the needs of both providers and patients in the realm of oral health. This strategic merger not only demonstrates a commitment to innovation and excellence in healthcare but also promises to reshape the future of diagnostics fundamentally. With next-generation solutions on the horizon, Real Diagnostics is poised to lead the industry into a new era of patient-centered care powered by advanced technology.

For more information on the latest developments and services, visit their website at www.realdxlabs.com.

What Lies Ahead

As HCAP Partners, the California-based private equity firm that supports Real Diagnostics, continues to invest in innovative healthcare solutions, we can expect to see further advancements and expansions in the laboratory's offerings. This acquisition is not merely an expansion of services; it is a brighter and more effective future for oral health diagnostics, affirming Real Diagnostics' position as a leader in the clinical laboratory landscape.